Avalo 制药 AVTX
$6.93 +$0.30 (+4.52%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.05 +1.73%
开盘$6.90
昨收$6.63
当日区间$6.53 – $7.01
成交量1.11M
市值$400.71M
市盈率（TTM）–
股息率–
AVTX 相关新闻
匹配 Avalo Therapeutics 或代码 AVTX 的头条新闻，按最新排序。
- Guggenheim Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Cuts Target Price to $48 负面
- A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $30 to $58
- Leerink Partners Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $38
- BofA Securities Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $35
- TD Cowen Maintains Avalo Therapeutics(AVTX.US) With Buy Rating
- Stifel Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $36
- Guggenheim Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $50
- BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $58 正面
- Citizens JMP Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $62 正面
- BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $58
- A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $55
- A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $58
- Piper Sandler Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $60 正面
- Wolfe Research Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $48
- Citizens JMP Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $52
暂无评论——快来第一个聊聊 AVTX。
登录后参与讨论。